L7 8XP) write: Interferon alfa-2b is used as maintenance treatment in patients with multiple myeloma.' Although renal toxicity is rare, mild proteinuria is common.2 We present
No takes yet. Share an insight, caveat, or question.
Fahal et al. (1993) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: